In this webinar, Dr Tony Dicker reviews Picato^® and its benefits for the treatment of solar keratosis. Dr Dicker discusses the use of lesion-directed therapies in a clinical setting, including the efficacy and skin reactions of Picato^®. Continue reading “[WEBINAR] Benefits and review of Picato for solar keratosis” →

In this month’s skin cancer update video, Professor Giuseppe Argenziano discusses how a new therapeutic agent, cemiplimab, might be used in combination with radiotherapy to treat advanced squamous cell carcinoma. Continue reading “[3 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [August 2019]” →

A drug typically used to treat breast cancer may also be effective in treating mucosal melanoma.

Continue reading “[4 min read] Breast cancer drug may treat mucosal melanoma” →

Australia is the skin cancer capital of the world, with two in three Australians diagnosed with the disease by the age of 70. A recent report looked at recommendations on behavioural counselling for the primary prevention of skin cancer. Continue reading “[4 min read] Behavioural counselling to prevent skin cancer” →

There has been a decline in the average hourly income for general practitioners as other specialists see a healthy rise in theirs, highlighting the need for GPs to diversify their skills and seek a field of subspecialisation. Continue reading “[8 min read] Decline in GP income calls for skills upgrade” →

In this month’s skin cancer update video, Professor Giuseppe Argenziano talks about an interesting patient case that demonstrates the importance of performing an examination of the entire skin surface – even if the patient is only concerned about one particular lesion – and highlights how dermoscopy can both enhance and change our understandings of lesions in the clinical setting. Continue reading “[2 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [July 2019]” →

In this month’s skin cancer update video, Professor Giuseppe Argenziano continues his two-part discussion from last month about the role of Imiquimod in the treatment of lentigo maligna. Using real patient case examples, Giuseppe discusses Imiquimod in an adjuvant setting, including how it can be applied in a clinical setting after surgery has been performed. Continue reading “[4 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [June 2019]” →

Skin cancer nurses play a vital role in the management and education of their patients, and advanced nursing has been found to correlate with high patient satisfaction (Wong and Chung 2006). Many skin cancer nurses also assess skin lesions at follow-up visits but have not progressed to a primary screening role. A study tested whether a skin cancer nurse’s understanding and powers of discrimination would make it safe for her to screen out patients whose lesions were definitely benign. Continue reading “[8 min read] The role of skin cancer nurses in screening patients” →

This month’s research article is from QIMR Berghofer Medical Research Institute in Brisbane, Australia. The authors consider the important question: what is the risk of melanoma recurrences among patients with a high-risk, localised melanoma? Continue reading “[3 min read] Risk of recurrence in patients with high-risk, localised melanoma” →

In this month’s skin cancer update video, Professor Giuseppe Argenziano talks about the role of Imiquimod in the treatment of primary melanoma. Using real patient case examples, Giuseppe describes the context in which Imiquimod can be utilised and the type of results physicians can expect. Continue reading “[3 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [May 2019]” →